MedPath

The DElhi DIabetes INTervention Trial (DEDINTT)

Not Applicable
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2023/07/054963
Lead Sponsor
ICMR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Participated in DEDICOM-II study

Exclusion Criteria

1. Cancer, renal, hepatic or intestinal disease requiring continuing treatment or hospital

admission ( >1 week in last 1 year).

2. Inability to communicate (due to mental illness or physical disability).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of the HbA1c levels between the groups 3 months after the start of intervention.Timepoint: 36 months
Secondary Outcome Measures
NameTimeMethod
1.Comparison of HbA1c in the groups at â??trial end pointâ?? <br/ ><br>2.Comparison of Lipid profile, blood pressure, drug compliance & preventive checks between the groups <br/ ><br>3.Comparison of sustainability of the gains in the groups <br/ ><br>Timepoint: 36 months
© Copyright 2025. All Rights Reserved by MedPath